290 related articles for article (PubMed ID: 19190159)
1. Serum high-density lipoprotein cholesterol and breast cancer risk by menopausal status, body mass index, and hormonal receptor in Korea.
Kim Y; Park SK; Han W; Kim DH; Hong YC; Ha EH; Ahn SH; Noh DY; Kang D; Yoo KY
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):508-15. PubMed ID: 19190159
[TBL] [Abstract][Full Text] [Related]
2. Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status.
Moorman PG; Hulka BS; Hiatt RA; Krieger N; Newman B; Vogelman JH; Orentreich N
Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):483-8. PubMed ID: 9641492
[TBL] [Abstract][Full Text] [Related]
3. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
Furberg AS; Veierød MB; Wilsgaard T; Bernstein L; Thune I
J Natl Cancer Inst; 2004 Aug; 96(15):1152-60. PubMed ID: 15292387
[TBL] [Abstract][Full Text] [Related]
4. CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk.
Han S; Lee KM; Choi JY; Park SK; Lee JY; Lee JE; Noh DY; Ahn SH; Han W; Kim DH; Hong YC; Ha E; Yoo KY; Kang D
Breast Cancer Res Treat; 2008 Jul; 110(2):387-93. PubMed ID: 17940865
[TBL] [Abstract][Full Text] [Related]
5. Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women.
Nichols HB; Trentham-Dietz A; Love RR; Hampton JM; Hoang Anh PT; Allred DC; Mohsin SK; Newcomb PA
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):41-7. PubMed ID: 15668474
[TBL] [Abstract][Full Text] [Related]
6. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
Tworoger SS; Missmer SA; Eliassen AH; Spiegelman D; Folkerd E; Dowsett M; Barbieri RL; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378
[TBL] [Abstract][Full Text] [Related]
7. Population frequency distributions of HDL, HDL(2), and HDL(3) cholesterol and apolipoproteins A-I and B in healthy men and women and associations with age, gender, hormonal status, and sex hormone use: the Stanford Five City Project.
Gardner CD; Tribble DL; Young DR; Ahn D; Fortmann SP
Prev Med; 2000 Oct; 31(4):335-45. PubMed ID: 11006058
[TBL] [Abstract][Full Text] [Related]
8. The association of carbohydrate intake, glycemic load, glycemic index, and selected rice foods with breast cancer risk: a case-control study in South Korea.
Yun SH; Kim K; Nam SJ; Kong G; Kim MK
Asia Pac J Clin Nutr; 2010; 19(3):383-92. PubMed ID: 20805083
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status.
Rusiecki JA; Holford TR; Zahm SH; Zheng T
Cancer Detect Prev; 2005; 29(5):419-26. PubMed ID: 16185815
[TBL] [Abstract][Full Text] [Related]
10. Association of paternal age at birth and the risk of breast cancer in offspring: a case control study.
Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Yoo KY; Kang D
BMC Cancer; 2005 Oct; 5():143. PubMed ID: 16259637
[TBL] [Abstract][Full Text] [Related]
11. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Rosner B; Sluss P; Hankinson SE
Cancer Res; 2004 Sep; 64(18):6814-9. PubMed ID: 15375001
[TBL] [Abstract][Full Text] [Related]
12. Dietary patterns and breast cancer risk in Korean women.
Cho YA; Kim J; Shin A; Park KS; Ro J
Nutr Cancer; 2010; 62(8):1161-9. PubMed ID: 21058205
[TBL] [Abstract][Full Text] [Related]
13. Anthropometric measures, plasma adiponectin, and breast cancer risk.
Tian YF; Chu CH; Wu MH; Chang CL; Yang T; Chou YC; Hsu GC; Yu CP; Yu JC; Sun CA
Endocr Relat Cancer; 2007 Sep; 14(3):669-77. PubMed ID: 17914097
[TBL] [Abstract][Full Text] [Related]
14. Alcohol and breast cancer risk defined by estrogen and progesterone receptor status: a case-control study.
Deandrea S; Talamini R; Foschi R; Montella M; Dal Maso L; Falcini F; La Vecchia C; Franceschi S; Negri E
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2025-8. PubMed ID: 18708394
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
[TBL] [Abstract][Full Text] [Related]
16. Adipocytokines and breast cancer risk.
Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
[TBL] [Abstract][Full Text] [Related]
17. Progestagens use before menopause and breast cancer risk according to histology and hormone receptors.
Fabre A; Fournier A; Mesrine S; Gompel A; Desreux J; Berrino F; Boutron-Ruault MC; Romieu I; Clavel-Chapelon F
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2723-8. PubMed ID: 18843015
[TBL] [Abstract][Full Text] [Related]
18. Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women.
Eliassen AH; Tworoger SS; Mantzoros CS; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):161-4. PubMed ID: 17220346
[TBL] [Abstract][Full Text] [Related]
19. Significance of alterations in plasma lipid profile levels in breast cancer.
Franky Dhaval Shah ; Shilin Nandubhai Shukla ; Pankaj Manubhai Shah ; Patel HR; Prabhudas Shankerbhai Patel
Integr Cancer Ther; 2008 Mar; 7(1):33-41. PubMed ID: 18292593
[TBL] [Abstract][Full Text] [Related]
20. Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study.
Bahl M; Ennis M; Tannock IF; Hux JE; Pritchard KI; Koo J; Goodwin PJ
Breast Cancer Res Treat; 2005 Nov; 94(2):135-44. PubMed ID: 16261412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
